We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.39B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.57B
AUM Growth
+$28.6M
Cap. Flow
-$101M
Cap. Flow %
-3.93%
Top 10 Hldgs %
15.36%
Holding
296
New
36
Increased
43
Reduced
179
Closed
35

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$31.9M
2
ROST icon
Ross Stores
ROST
+$31.4M
3
FL
Foot Locker
FL
+$28.8M
4
BBBY
Bed Bath & Beyond Inc
BBBY
+$28.5M
5
TM icon
Toyota
TM
+$11.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.46%
2 Technology 19.31%
3 Healthcare 14.65%
4 Financials 10.08%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
26
Pultegroup
PHM
$25.2B
$33.5M 1.3%
1,559,430
-78,679
-5% -$1.57M
AXP icon
27
American Express
AXP
$224B
$33.4M 1.3%
358,903
-15,905
-4% -$1.43M
AMTD
28
DELISTED
TD Ameritrade Holding Corp
AMTD
$32.9M 1.28%
919,329
-48,613
-5% -$1.65M
TXN icon
29
Texas Instruments
TXN
$248B
$32.2M 1.25%
601,665
-29,383
-5% -$1.49M
DIS icon
30
Walt Disney
DIS
$171B
$31.8M 1.24%
337,153
-16,204
-5% -$1.46M
EMC
31
DELISTED
EMC CORPORATION
EMC
$31.7M 1.23%
1,064,844
-40,163
-4% -$1.17M
ELV icon
32
Elevance Health
ELV
$81.5B
$31.7M 1.23%
251,859
-12,895
-5% -$1.59M
BLK icon
33
Blackrock
BLK
$167B
$31.6M 1.23%
88,403
-4,363
-5% -$1.49M
BRCM
34
DELISTED
BROADCOM CORP CL-A
BRCM
$31.5M 1.23%
726,078
-29,879
-4% -$1.22M
BIIB icon
35
Biogen
BIIB
$30.9B
$31.5M 1.23%
92,676
-3,905
-4% -$1.26M
DHR icon
36
Danaher
DHR
$138B
$31.4M 1.22%
544,633
-24,336
-4% -$1.32M
BEN icon
37
Franklin Resources
BEN
$16.8B
$31.4M 1.22%
566,458
-19,879
-3% -$1.1M
LRCX icon
38
Lam Research
LRCX
$316B
$31.4M 1.22%
3,951,800
-791,460
-17% -$6.14M
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
$31.2M 1.22%
368,507
-20,842
-5% -$1.63M
BBBY
40
DELISTED
Bed Bath & Beyond Inc
BBBY
$31.1M 1.21%
+408,090
New +$28.5M
NTAP icon
41
NetApp
NTAP
$33.9B
$29.7M 1.16%
716,120
-21,941
-3% -$911K
SNDK
42
DELISTED
SANDISK CORP
SNDK
$29.4M 1.14%
299,609
-10,425
-3% -$997K
SNPS icon
43
Synopsys
SNPS
$71.6B
$29.2M 1.14%
671,290
-28,276
-4% -$1.17M
FL
44
DELISTED
Foot Locker
FL
$29.1M 1.14%
+518,750
New +$28.8M
BA icon
45
Boeing
BA
$169B
$29.1M 1.13%
223,708
-5,603
-2% -$710K
BKNG icon
46
Booking.com
BKNG
$156B
$28.2M 1.1%
619,000
-16,350
-3% -$738K
CMI icon
47
Cummins
CMI
$83.6B
$28.1M 1.1%
195,007
-5,289
-3% -$748K
ARW icon
48
Arrow Electronics
ARW
$10.5B
$27.8M 1.08%
479,517
-23,757
-5% -$1.32M
GILD icon
49
Gilead Sciences
GILD
$165B
$27.7M 1.08%
293,509
-9,881
-3% -$1.02M
QCOM icon
50
Qualcomm
QCOM
$164B
$26.6M 1.04%
357,662
-4,508
-1% -$330K

Similar funds

Renaissance Group's Q4 2014 Portfolio in Review

As of Q4 2014, Renaissance Group held 296 positions worth $2.57B, up 1.1% from $2.54B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Renaissance Group withdrew a net $101M in Q4 2014, closing 35 positions and reducing 179 holdings. Its most notable exit was Allergan Inc, an estimated $31M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Renaissance Group opened a new position in Edwards Lifesciences worth $33.7M.

  • Renaissance Group's largest Q4 2014 buy was Edwards Lifesciences: 1,588,260 shares worth $33.7M.
  • Renaissance Group added most to Icon in Q4 2014, an estimated $11M increase.
  • Renaissance Group's biggest Q4 2014 reduction was Packaging Corp of America, cutting an estimated $30.4M.
  • Renaissance Group fully exited Allergan Inc in Q4 2014, selling an estimated $31M.
  • Renaissance Group's ten largest holdings make up 15% of its $2.57B portfolio in Q4 2014.
  • Renaissance Group opened 36 new positions and closed 35 in Q4 2014.
  • Renaissance Group's portfolio value rose 1.1% quarter-over-quarter to $2.57B.

Based on Renaissance Group's 13F filing for Q4 2014, filed 10 Feb 2015.